आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

auden mckenzie (pharma division) ltd - paracetamol, dihydrocodeine bitartrate - tablets - 20/500 milligram - dihydrocodeine and paracetamol

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

auden mckenzie (pharma division) ltd - paracetamol, dihydrocodeine bitartrate - tablets - 30/500 milligram - dihydrocodeine and paracetamol

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

galen limited - paracetamol dihydrocodeine bitartrate - tablets - 10/500 milligram

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

physicians total care, inc. - dihydrocodeine bitartrate (unii: 8lxs95bsa9) (dihydrocodeine - unii:n9i9hdb855), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - dihydrocodeine bitartrate 32 mg - acetaminophen, caffeine, and dihydrocodeine bitartrate tablets are indicated for the relief of moderate to moderately severe pain. this combination product is contraindicated in persons with hypersensitivity to dihydrocodeine, codeine, acetaminophen, caffeine, or any of the inactive components listed above, or any situation where opioids are contraindicated including significant respiratory depression (in unmonitored settings or in the absence of resuscitative equipment), acute or severe bronchial asthma or hypercapnia, and paralytic ileus. this combination product is subject to the provisions of the controlled substance act, and has been placed in schedule iii. dihydrocodeine can produce drug dependence of the codeine type and therefore has the potential of being abused. like other opioid analgesics, dihydrocodeine may produce subjective effects other than analgesia (e.g., euphoria, relaxation), which may contribute to abuse by some patients. psychological dependence, physical dependence, and tolerance may d

माल्टा - अंग्रेज़ी - Medicines Authority

wockhardt uk limited - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics

माल्टा - अंग्रेज़ी - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - dihydrocodeine tartrate - tablet - dihydrocodeine tartrate 30 mg - analgesics

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - dihydrocodeine hydrogen tartrate 60mg - modified release tablet - 60 mg - active: dihydrocodeine hydrogen tartrate 60mg excipient: calcium sulfate dihydrate copovidone glyceryl behenate sodium stearyl fumarate - dihydrocodeine controlled release actavis tablets are recommended for use in the treatment of post-operative pain, and pain associated with cancer.

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - dihydrocodeine tartrate - oral tablet - 30mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - dihydrocodeine tartrate - oral tablet - 30mg

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - dihydrocodeine tartrate - oral tablet - 30mg